Medicine and Dentistry
Ovarian Cancer
100%
Neoplasm
43%
Cancer Cell
20%
Uterine Cancer
18%
Malignant Neoplasm
18%
Homologous Recombination
15%
Overall Survival
14%
Olaparib
14%
Gynecological Oncology
12%
DNA Repair
12%
Krukenberg Tumor
12%
Cancer Growth
12%
Histone Deacetylase Inhibitor
11%
Wart Virus
11%
Tumor Cell
11%
PARP Inhibitor
10%
Cyclooxygenase 1
10%
Organoid
10%
Macrophage
10%
DNA Damage
9%
Metastatic Carcinoma
9%
Ovarian Tumor
9%
Cancer
9%
Cell Viability
9%
Ascites
9%
Ovarian Cancer Survival
8%
Surgeon
8%
Clear Cell Carcinoma
7%
Programmed Cell Death
7%
Diseases
7%
Female Genital Tract Cancer
7%
Cytotoxicity
6%
Breast Cancer
6%
BRCA1
6%
Adenocarcinoma
6%
Tumor Microenvironment
6%
Radiation Therapy
5%
Gene Expression
5%
Protein P53
5%
Medical Record
5%
In Vitro
5%
Body Mass Index
5%
Panobinostat
5%
COVID-19
5%
Wart Virus Vaccine
5%
Health Disparity
5%
Tumor Necrosis Factor
5%
Randomized Controlled Trial
5%
Cell Line
5%
Keyphrases
Ovarian Cancer
72%
Ovarian Cancer Cells
32%
Tumor
21%
Overall Survival
17%
Endometrial Cancer
16%
Cyclooxygenase-1 (COX-1)
15%
Histone Deacetylase Inhibitor (HDACi)
15%
Olaparib
13%
DNA Damage
13%
Ovarian Tumor
13%
Tumor Cells
12%
Gynecologic Oncology
12%
High-grade Serous Ovarian Cancer (HGSOC)
12%
Ovarian Cancer Patients
11%
Epithelial Ovarian Cancer
11%
PARP Inhibitor (PARPi)
10%
Ovarian Cancer Survival
10%
Ascites
10%
Small Molecules
9%
Confidence Interval
8%
Cell Viability
8%
Hazard Ratio
8%
Homologous Recombination Proficient
8%
DNA Repair
8%
Academic Surgeon
8%
Nuclear factor-κB
7%
Gynecological Cancer
7%
Black Academics
7%
Cisplatin
7%
FK228
7%
Tumor-associated Macrophages
7%
Tumor Necrosis Factor-α
6%
Cancer Tumor
6%
Tumor Microenvironment
6%
SKOV3
6%
Solid Tumors
6%
Histone Deacetylase 3 (HDAC3)
6%
Overexpression
6%
Metastatic Tumor
6%
Macrophages
6%
Aspirin
5%
RAD51
5%
Romidepsin
5%
Uterine Serous Carcinoma
5%
Syngeneic
5%
Chemotherapy
5%
Black Women
5%
Cancer Cell Growth
5%
Syngeneic Mouse Model
5%
NF-B
5%